|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 0.0650 USD | -5.52% |
|
-56.29% | -100.00% |
| 10-08 | Top Premarket Decliners | MT |
| 08-05 | Top Premarket Decliners | MT |
Company Valuation: China SXT Pharmaceuticals, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | - | - | 2.722 | 0.8064 | 34.31 | 1.434 |
| Change | - | - | - | -70.38% | 4,154.69% | -95.82% |
| Enterprise Value (EV) 1 | - | - | -5.686 | -7.569 | 17.06 | -25.77 |
| Change | - | - | - | -33.12% | 325.35% | -251.06% |
| P/E | -499,740,352x | -4,767,301x | - | - | - | - |
| PBR | - | 0.82x | 0.23x | 0.27x | 2.22x | 0.05x |
| PEG | - | -3,188x | - | - | - | - |
| Capitalization / Revenue | - | - | 1.38x | 0.42x | 19.7x | 1.26x |
| EV / Revenue | - | - | -2.88x | -3.92x | 9.8x | -22.6x |
| EV / EBITDA | - | - | 1.14x | 4.01x | -6.56x | 3.66x |
| EV / EBIT | - | - | 1.08x | 3.62x | -6.36x | 3.62x |
| EV / FCF | - | - | -3.19x | 6.19x | -6.19x | 5.44x |
| FCF Yield | - | - | -31.4% | 16.2% | -16.1% | 18.4% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.177 | -2.824 | - | - | - | - |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 4.778 | 2.602 | 1.972 | 1.928 | 1.741 | 1.138 |
| EBITDA 1 | -1.852 | -4.87 | -5.008 | -1.889 | -2.598 | -7.049 |
| EBIT 1 | -2.197 | -5.19 | -5.258 | -2.092 | -2.68 | -7.123 |
| Net income 1 | -2.748 | -5.736 | -5.935 | -3.099 | -3.304 | -6.205 |
| Net Debt 1 | -0.6256 | -4.328 | -8.408 | -8.375 | -17.25 | -27.2 |
| Reference price 2 | 88,461,538.4615 | 13,461,538.4615 | 680,585.5532 | 161,279.4839 | 29,938.6323 | 134.4000 |
| Nbr of stocks (in thousands) | - | - | 0 | 0.01 | 1.15 | 10.7 |
| Announcement Date | 8/13/21 | 7/18/22 | 7/31/23 | 8/13/24 | 7/31/25 | 7/1/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 85.89K | |
| 35.96x | 12.96x | 27.14x | 0.55% | 1,120B | |
| 37.4x | 6.3x | 17.74x | 2.09% | 616B | |
| 36.43x | 8.36x | 17.24x | 2.43% | 504B | |
| 20.46x | 4.99x | 12.38x | 2.64% | 367B | |
| 106.52x | 5.95x | 25.12x | 2.33% | 360B | |
| 21.18x | 5.54x | 13.63x | 2.88% | 288B | |
| 21.7x | 4.38x | 12.55x | 2.01% | 258B | |
| 27.46x | 7.06x | 12.64x | 2.33% | 234B | |
| -45.63x | 6.99x | 27.07x | 2.11% | 194B | |
| Average | 29.05x | 6.95x | 18.39x | 2.15% | 394.09B | |
| Weighted average by Cap. | 34.72x | 8.20x | 20.04x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SXTC Stock
- Valuation China SXT Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
